Drug Trial Radar · NCT01211873
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Last checked: Nov 20, 2026Latest source record: Apr 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
416
Actual
Start
Sep 2010
Primary completion
Nov 2011
Study completion Nov 2011
Sponsor
- Lead sponsor
- GuerbetIndustry
- Sponsor type
- Industry
- First posted
- Sep 30, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to look at the safety (what are the side effects)and efficacy (how well does it work) of Dotarem® when used in taking images of the brain / spine. The results will be compared to the results of MRI taken without Dotarem.
Conditions
- Diagnostic Self Evaluation
- Central Nervous System Diseases
Interventions
Dotarem (gadoterate meglumine)Drug
0.1 mmol/kg by body weight, single IV injection
Magnevist (gadopentetate dimeglumine)Drug
0.1 mmol/kg by body weight, single IV injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- MRI Lesion Visualization (Border Delineation, Internal Morphology and Contrast Enhancement) at Patient Level for Both "Pre" and "Paired" EvaluationTime frame: up to 24 hours
Locations
52 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham, UABMC
Birmingham, Alabama
University Medical Center
Tucson, Arizona
University medical center
Tucson, Arizona
Desert Medical Imaging
Indian Wells, California
Sunrise Clinical Research, Inc.
Hollywood, Florida
Children's Memorial Hospital
Chicago, Illinois
Precise Clinical Research Solutions
Topeka, Kansas
University of Louisville Hospital
Louisville, Kentucky
Neurocare Center for Research
Brookline, Massachusetts
University of Michigan
Ann Arbor, Michigan
QUEST Research Institute
Farmington Hills, Michigan
Gruss Magnetic resonance Research Clinic
New York, New York
WestImage - Division of Research
Cincinnati, Ohio
Ohio State University
Columbus, Ohio
Medical University of South Carolina
Charleston, South Carolina
University of Texas - Health Science Center
San Antonio, Texas
UTHSCSA
San Antonio, Texas
Clinical Trials of Texas, Inc.
San Antonio, Texas
University of Washington Medical Center
Seattle, Washington
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
Centro de Diagnóstico
Buenos Aires, Argentina
Hospital Italiano
Buenos Aires, Argentina
TCBA
Buenos Aires, Argentina
Univ.-institut f.Radiodiagnostik
Salzburg, Austria
Landesklinikum Tulln
Tulln, Austria
Medical University of Vienna
Vienna, Austria
Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil
Universidade Federal de São Paulo / UNIFESP
São Paulo, Brazil
Departamento de Neuroradiologia
Santiago, Chile
Instituto de Neurocirugia Dr. Asenjo,
Santiago, Chile
Hôpital Pellegrin
Bordeaux, France
Hôpital Roger Salengro- CRHU de Lille
Lille, France
Hôpital Gui De Chauliac
Montpellier, France
Centre Hospitalier Sainte Anne
Paris, France
Radiologie A - Hôpital de la Milétrie
Poitiers, France
Fédération d'Imagerie Médicale,Hôpital Pontchaillou
Rennes, France
University Hospital Charite
Berlin, Germany
Krankenhaus Nordwest GmbH
Frankfurt, Germany
University Hospital Frankfurt
Frankfurt am Main, Germany
University of Heidelberg
Heidelberg, Germany
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.